The largest database of trusted experimental protocols

Facsdiva flow cytometry software version 6

Manufactured by BD
Sourced in United States

BD FACSDiva™ Flow Cytometry Software Version 6.1.2 is a computer program designed to control and analyze data from BD flow cytometers. It provides a user interface for setting up and running flow cytometry experiments, as well as tools for analyzing the collected data.

Automatically generated - may contain errors

8 protocols using facsdiva flow cytometry software version 6

1

Flow Cytometry Analysis of Siglec Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed using a LSR Fortessa with BD FACSDiva Flow Cytometry Software Version 6.2 (BD Biosciences). Compensation was done with BD™ CompBeads Set Anti-Mouse Ig, κ (BD Biosciences). For gating the Siglec positive cells, a tube without Siglec antibodies (fluorescence minus one (FMO)) served as control. Furthermore, an isotype control was used to visualize possible unspecific binding of the antibodies to FC receptors.
Data was analysed using FACSDiva Flow Cytometry Software Version 6.2 and FlowJO 10 (FlowJo LLC, Ashland, USA).
+ Open protocol
+ Expand
2

FACS Analysis of NK Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
FACS (Fluorescence Activated Cell Sorting) analysis was performed using the following mouse anti-rat mAbs: CD3 conjugated with allophycocyanin (T cell receptor/CD3 APC), and CD161a conjugated with phycoerythrin (NK cells/NKRP1A+/CD161abright PE, BD Biosciences, San Diego, USA). Protected from light, cells were incubated for 30 min at 4 °C. Thereafter, PBMCs were washed twice with washing buffer (PBS supplemented with 1% BSA and 0.1% sodium azide), resuspended in measuring buffer (PBS supplemented with 0.1% BSA and 0.1% sodium azide) and samples were analyzed by flow cytometry using LSR Fortessa with BD FACSDiva Flow Cytometry Software Version 6.2 (BD Biosciences, San Diego, USA; Fig. 1). NK cells are represented by the CD161abright/CD3 population.

Representative scatter-plot of flow cytometry analysis. NK cells are represented by cells with CD161abright and CD3 expression and denoted with NK cells

+ Open protocol
+ Expand
3

Mitochondrial Membrane Potential Assay of MCF7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MCF7 cells were treated with compound 1, and the integrity of MMP was analyzed using 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1; Biomol, Hamburg, Germany) staining as previously reported [16] (link), [17] (link), [18] (link), [19] (link). Cells (3 mL, 1 × 105 cells/ml) treated for 72 h (humidified 5% CO2 atmosphere at 37 °C) with different concentrations (¼ × IC50, ½ × IC50 and IC50) of compound 1, and doxorubicin (drug control) or DMSO (solvent control) were incubated with JC-1 staining solution for 30 min according to the manufacturer's protocol [16] (link). Cells were then measured in a BD FACS Aria I Cell Sorter Flow Cytometer (Becton–Dickinson, Germany). The JC-1 signal was measured at an excitation of 561 nm (150 mW) and detected using a 586/15 nm band-pass filter. The signal was analyzed at 640 nm excitation (40 mW) and detected using a 730/45 nm bandpass filter. Cytographs were analyzed using BD FACSDiva™ Flow Cytometry Software Version 6.1.2 (Becton–Dickinson). All experiments were performed in triplicates.
+ Open protocol
+ Expand
4

Cell Cycle Analysis of MCF7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of compound 1 in cell cycle distribution of MCF7 cells was performed by flow cytometry using BD cycle test™ Plus DNA Kit Assay (BD Biosciences, San Jose, USA) as previously described [16] (link). Briefly, MCF-7 cells (3 ml, 1 × 105 cells/ml) were seeded into each well of 6-well plates and allowed to attach for 24 h (humidified 5% CO2 atmosphere at 37 °C). Cells treated with ¼ × IC50, ½ × IC50 and IC50 concentrations of compound 1 and doxorubicin as well as untreated cells (control) were then grown in 6-well plates for 72 h. The BD FACS Aria I Cell Sorter Flow Cytometer (Becton–Dickinson, Germany) was then used for cell cycle analysis. For each sample 104 cells were counted. For PI excitation, an argon-ion laser emitting at 488 nm was used. Cytographs were analyzed using BD FACSDiva™ Flow Cytometry Software Version 6.1.2 (Becton–Dickinson).
+ Open protocol
+ Expand
5

Assessing Mitochondrial Membrane Potential in MCF-7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MMP was analyzed in MCF-7 cells by 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1; Biomol, Hamburg, Germany) staining as previously reported [18 (link)–20 (link)]. Cells (3 mL, 1 × 105 cells/mL) treated for 72 h with different concentrations (¼ × IC50, ½ × IC50 and IC50) of EMW, KCL and doxorubicin (drug control) or DMSO (solvent control) were incubated with JC-1 staining solution for 30 min according to the manufacturer’s protocol, as earlier reported. Subsequently, cells were measured in a BD FACS Aria I Cell Sorter Flow Cytometer (Becton-Dickinson, Germany). The JC-1 signal was measured at an excitation of 561 nm (150 mW) and detected using a 586/15 nm band-pass filter. The signal was analyzed at 640 nm excitation (40 mW) and detected using a 730/45 nm bandpass filter. Cytographs were analyzed using BD FACSDiva™ Flow Cytometry Software Version 6.1.2 (Becton-Dickinson). All experiments were performed at least in triplicates.
+ Open protocol
+ Expand
6

Cell Cycle Analysis of Anticancer Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell-cycle analysis was performed by flow cytometry using BD cycletest™ Plus DNA Kit Assay (BD Biosciences, San Jose, USA). The BD Cycletest™ Plus DNA kit provides a set of reagents for isolating and staining cell nuclei. Flow cytometric analysis of differentially stained cells is used to estimate the DNA index (DI) and cell-cycle phase distributions. Briefly, MCF-7 cells (3 mL, 1 × 105 cells/mL) were seeded into each well of 6-well plates and allowed to attach for 24 h. The cells which were treated with ¼ × IC50, ½ × IC50 and IC50 concentrations of Elephantopus mollis whole plant (EMW) and Kalanchoe crenata leaves (KCL) extracts and the standard drug, doxorubicin, and grown for 72 h. The untreated cells (control) were also included in the assay. They were further trypsinized and suspended in 1 mL PBS, then centrifuged at 400 g for 5 min at room temperature (RT). The cells were further processed according to the manufacturer’s protocol [16 (link)]. The cells were further measured on a BD FACS Aria I Cell Sorter Flow Cytometer (Becton-Dickinson, Germany). For each sample 104 cells were counted. For PI excitation, an argon-ion laser emitting at 488 nm was used. Cytographs were analyzed using BD FACSDiva™ Flow Cytometry Software Version 6.1.2 (Becton-Dickinson).
+ Open protocol
+ Expand
7

Cell Cycle Analysis of MCF-7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of compounds 9 and 13 and doxorubicin (positive control) in cell cycle distribution of MCF-7 cells was performed by flow cytometry using BD cycletest™ Plus DNA Kit Assay (BD Biosciences, San Jose, USA) as previously described [23 (link)]. Cells were tested in 6-well plates (3 mL, 1 × 105 cells/mL) and the incubation time was 72 h in humidified 5% CO2 atmosphere at 37 °C. The tested concentrations were ¼ × IC50, ½ × IC50 and IC50. Untreated cells (control) were used for comparison with treated cells. The BD FACS Aria I Cell Sorter Flow Cytometer (Becton-Dickinson, Germany) was then used for cell cycle analysis. For each sample, 104 cells were counted. For PI excitation, an argon-ion laser emitting at 488 nm was used. Cytographs were analyzed using BD FACSDiva™ Flow Cytometry Software Version 6.1.2 (Becton-Dickinson).
+ Open protocol
+ Expand
8

Mitochondrial Membrane Potential Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MCF-7 cells were treated with compounds 9 and 13 and doxorubicin, and the integrity of MMP was analyzed using 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1; Biomol, Hamburg, Germany) staining as previously reported [27 (link)–29 (link)]. Cells were tested in 6-well plates (3 mL, 1 × 105 cells/mL) and the incubation time was 72 h in humidified 5% CO2 atmosphere at 37 °C. The tested concentrations were ¼ × IC50, ½ × IC50 and IC50. Untreated cells (control) were used for comparison with treated cells. JC-1 staining was performed according to the manufacturer’s protocol as reported previously [23 (link)]. Cells were then measured in a BD FACS Aria I Cell Sorter Flow Cytometer (Becton-Dickinson, Germany). The JC-1 signal was measured at an excitation wavelength of 561 nm (150 mW) and detected using a 586/15 nm band-pass filter. The signal was analyzed at an excitation wavelength of 640 nm (40 mW) and detected using a 730/45 nm bandpass filter. Cytographs were analyzed using BD FACSDiva™ Flow Cytometry Software Version 6.1.2 (Becton-Dickinson). All experiments were performed at least in triplicates.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!